KELLI LANDRUM: Open Payments
NPI 1437526894 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 20 payments from 14 companies in 2025. Trend: 2023 $1,490 · 2024 $1,007 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $230 |
| Abbott Laboratories | 2 | $209 |
| Axsome Therapeutics, Inc. | 2 | $152 |
| KYOWA KIRIN, INC. | 1 | $130 |
| Amgen Inc. | 1 | $129 |
| Astellas Pharma US Inc | 1 | $129 |
| Ardelyx, Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| PFIZER INC. | 1 | $94 |
Products named: VRAYLAR, XIFAXAN, FREESTYLE LIBRE 3, Auvelity, REPATHA, Veozah, IBSRELA, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
